Jenni E. Keskitalo

ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

P. Neuvonen, M. Niemi, M. Fromm, 2009, Clinical pharmacology and therapeutics.

ABCB1 Haplotypes Differentially Affect the Pharmacokinetics of the Acid and Lactone Forms of Simvastatin and Atorvastatin

P. Neuvonen, M. Niemi, Kaisa J. Kurkinen, 2008, Clinical pharmacology and therapeutics.

UDP‐Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo

M Schwab, U. Hofmann, P. Neuvonen, 2010, Clinical pharmacology and therapeutics.

Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin.

P. Neuvonen, M. Niemi, M. Pasanen, 2009, Pharmacogenomics.

No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.

P. Neuvonen, M. Niemi, J. Backman, 2009, British journal of clinical pharmacology.